Growth Stock Wire Investment Newsletter

 
Growth Stock Wire Investment Newsletter About Growth Stock Wire Frequently Asked Questions Growth Stock Wire Archives Contact Us Privacy Policy
Print Edition | Sponsored Link:
A Big "Breakout" Traders Must Pay Attention To
By Brian Hunt
June 29, 2009

Last week, we saw a development that all traders need to make special note of.

It has the potential to make you a lot of money over the coming year...

The development comes down to what I call a "breakout."

A breakout occurs when an asset reaches a new high for a given period of time. In our Penny Trends trading advisory, we monitor three-month breakouts. We believe it's a good "middle of the road" timeframe that gets us into trends early enough for big gains... but not so early that we buy assets while they are stumbling near their lows.

On Thursday, both the health care sector and the biotech sector staged breakouts. Below is this bullish action in the major health care ETF:


Many investors think health care stocks are in for rough times. The White House has made clear that it wants to wring out some profits enjoyed by many companies. This is a negative for health care stock prices.

But there's another belief out there... one that says the efforts of the White House will actually drive up health care spending. Governments can barely manage parking meters, so it wouldn't surprise us to see their efforts producing more health care spending over the coming years.

More government oversight may lower profit margins a bit, but new "health care for everyone" programs could create more demand with government aid (which, of course, comes out of your wallet). This would send more money the way of many health care companies.

 
Related Articles
This Sector is a Triple-Digit-Winner Machine
These Stocks Rise Faster Than Any Other Investment Class in the World
 
In Penny Trends, we don't make predictions. Sure, we develop trading plans based on our analysis of fundamental market conditions, but they take a backseat to what the market tells us. The market is never wrong. The trend is never wrong... and a trader's No. 1 job is to get on the right side of the trend.

The short-term trend is bullish for health care stocks (their close cousin biotech stocks are enjoying the same exact price action)... which means one has to be a buyer right now.

Good trading,

Brian Hunt

P.S. If you're looking to make the biggest gains from the health care and biotech uptrend, I recommend you become a Penny Trends reader soon. A good rally here will cause the market's most promising microcap players to soar. Click here if you're not a subscriber and want to learn about our latest recommendation.

Wealthy pensioners kidnap and torture financial advisor who lost millions
Details: beaten with a walker... burned with cigarettes... "chained up like an animal"

The least politically correct oil company name in history
Russia's Nigerian joint venture is unfortunately named...

Marc Faber: We'll soon see inflation of 10%-20%
Says gov't inflation statistics are "a lie."


Tons of biotech stocks breaking out to three- and six-month highs... new biotech boom may be at hand.
Businesses are paying their debts... corporate bond fund LQD nears new highs.
Chinese video game firm Perfect World soars to new high... up more than 200% in the past four months.
Earnings today... Apollo Group, H&R Block.
Last Change 52-Wk
S&P 500 900.94 +0.65% -31.45%
Oil (USO) 37.09 -0.86% -66.57%
Gold (GLD) 91.45 +0.58% +4.55%
Silver (SLV) 13.68 +0.44% -17.05%
U.S. Dollar 80.75 +0.25% +10.78%
Euro
1.40
+0.20%
-10.94%
VIX 29.05 -5.00% +29.57%
HUI 342.83 +3.34% -17.08%
10-Year Yield 3.68% 0.05 -0.38

Advertisement

Company Sym Industry

Todd Shipyards

TOD

shipbuilding

Lannett

LCI

pharma

Bovie Medical

BVX

medical devices

German American

GABC

bank

Avanir Pharma

AVNR

pharma

York Water

YORW

water utilities

ClickSoftware 

CKSW

software

Kirklands

KIRK

furniture

Spectrum Pharma

SPPI

pharma

BioScrip

BIOS

health services

Cray

CRAY

mainframes

Anaren

ANEN

telecom

Atrion

ATRI

medical devices

ArQule

ARQL

pharma

Cantel Medical

CMN

medical devices

Isramco

ISRL

drilling

Dollar Thrifty

DTG

rental cars

Protalix

PLX

biotech

IMAX

IMAX

movie theatres

Noven Pharma

NOVN

pharma

Stein Mart

SMRT

clothing stores

American Capital

AGNC

residential REIT

Spartan Motors

SPAR

trucks

Lincoln Edu

LINC

education

Acme Packet

APKT

telecom

VanceInfo Tech

VIT

software

3PAR

PAR

data storage

Aruba Networks

ARUN

networks

99 Cents Only

NDN

dollar stores

Duoyuan Global

DGW

water utilities

Hatteras Financial

HTS

virtual bank

MedAssets

MDAS

health care IT

STEC

STEC

data storage

Perfect World

PWRD

online games

Rackspace

RAX

networks

Silicon Labs

SLAB

semiconductors

Amylin Pharma

AMLN

biotech

AmeriGas

APU

utility

Palm

PALM

cell phones

Valeant Pharma

VRX

pharma

Biovail

BVF

medical devices

Allscripts Misys

MDRX

health care IT

Watson Pharma

WPI

generic drugs

Cerner

CERN

health care IT

Vertex Pharma

VRTX

pharma

Kubota

KUB

heavy equipment

Company Sym Industry

Heckmann

HEK

acquisitions

Chemspec Intl

CPC

chemicals

Caraco Pharma

CPD

generic drugs

UTEK

UTK

business services

Pacific Capital

PCBC

bank

Immucor

BLUD

diagnostics

Weekend Edition: Fed Up with the Government's Funny Money
June 27, 2009

Biotech's Latest Hot-Money Trend
June 26, 2009

The Year's Best Opportunity to Profit on Oil
June 25, 2009

Commodity Q&A: Is It Time to Short Oil?
June 24, 2009

Another Ominous Sign for Stock Prices
June 23, 2009

Home | About GSW | FAQ | GSW Archive | Privacy Policy | Contact Us

Customer Service: 1-888-261-2693 – Copyright 2010 Stansberry & Associates Investment Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This e-letter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry & Associates Investment Research, LLC. 1217 Saint Paul Street, Baltimore MD 21202